Maddy Griffith

Title(s)Project Manager, Institute for Health & Aging
SchoolSchool of Nursing
Address490 Illinois Street, #1200
San Francisco CA 94158
PronounsShe/Her/Hers
ORCID ORCID Icon0009-0002-4714-1815 Additional info
vCardDownload vCard

Collapse Biography 
Collapse Education and Training
UC Berkeley, Berkeley, CAMPH05/2023Maternal, Child, Adolescent Health
UC Berkeley, Berkeley, CA05/2023Graduate Certificate in Applied Data Science
UC Berkeley Extension11/2019Clinical Project Management
UC Berkeley Extension08/2019Clinical Research Training
UC Santa Barbara, Santa Barbara, CABS06/2015Biopsychology
Collapse Awards and Honors
UC San Francisco2023  - 2024STAR Achievement Award

Collapse Overview 
Collapse Overview
Maddy Griffith is a Project Policy Analyst III and works on a variety of global and domestic research projects related to sexual and reproductive health, implementation science, and program evaluation. Projects include the Innovations for Choice and Autonomy (ICAN) implementation research project in Kenya, Malawi, Nigeria, and Uganda, where Maddy manages implementation research and program evaluation workstreams in Nigeria and Uganda, supports qualitative and quantitative data management, analysis, and research dissemination efforts. She also manages two DCE-focused research projects: one on self-managed abortion preferences in Mississippi, and another on PrEP preferences among young men in South Africa. She has extensive experience with clinical research coordination and project management, and is interested in promoting reproductive health and education for all, particularly underserved populations. Maddy completed her MPH in Maternal, Child, and Adolescent Health at UC Berkeley, and her BS in Biopsychology at UC Santa Barbara.

Collapse Bibliographic 
Collapse Publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. How do pro-social tendencies and provider biases affect service delivery? Evidence from the rollout of self-injection of DMPA-SC in Nigeria. BMC Womens Health. 2025 Mar 04; 25(Suppl 1):97. Chiu C, Tijani A, Griffith M, Himes E, Challa S, Okoli C, Dimowo S, Jegede A, Liu JX. PMID: 40038661; PMCID: PMC11877756.
    View in: PubMed
  2. Electronic Coding for Abnormal Fecal Immunochemical Test Is Associated With Increased Colonoscopy Completion. Am J Gastroenterol. 2024 07 01; 119(7):1431-1432. Burns S, Griffith M, Patel S, Sarkar U, Somsouk M. PMID: 38488169; PMCID: PMC11686599.
    View in: PubMed   Fields:    Translation:Humans
  3. Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma. J Immunother Cancer. 2023 01; 11(1). Sinha M, Betts C, Zhang L, Griffith MJ, Solman I, Chen B, Liu E, Tamaki W, Stultz J, Marquez J, Sivagnanam S, Cheung A, Pener D, Fahlman A, Taber E, Lerner K, Crocker M, Todd K, Rajagopalan B, Ware C, Bridge M, Vo J, Dragomanovich H, Sudduth-Klinger J, Vaccaro G, Lopez CD, Tempero M, Coussens LM, Fong L. PMID: 36593070; PMCID: PMC9809229.
    View in: PubMed   Mentions: 3   Article has an altmetric score of 8    Fields:    Translation:HumansCTClinical Trials
  4. Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases. BMC Cancer. 2022 Dec 13; 22(1):1307. Fidelman N, Atreya CE, Griffith M, Milloy MA, Carnevale J, Cinar P, Venook AP, Van Loon K. PMID: 36514060; PMCID: PMC9749246.
    View in: PubMed   Mentions: 1   Fields:    Translation:HumansCTClinical Trials